Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Michael A. Curran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4996-7207; OpenAlex author ID A5065861312. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
31
Papers, trials and grants by year

2018: 1 paper, 1 grant · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 5

  1. IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancer. Co-author DOI 10.1038/s41598-026-42259-8↗
  2. Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration. Last author DOI 10.1172/jci.insight.169150↗
  3. Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Co-author DOI 10.1126/sciadv.add6995↗
  4. High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Last author DOI 10.1136/jitc-2021-003246↗
  5. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/scitranslmed.aat3487↗

Grants 1

  1. Pro-Inflammatory Conversion of the PDAC Microenvironment AWARD pancan:2018-michael-curran-phd-pro-inflammatory-conversion-of-the-pdac-

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akash R. Boda · 3 shared papers, 2021–2026 · strength 0.61
  2. David R Piwnica-Worms · 2 shared papers, 2023–2024 · strength 0.35
  3. Casey R. Ager · 2 shared papers, 2021–2024 · strength 0.34
  4. Manisha Singh · 1 shared paper, 2026 · strength 0.27
  5. Saikat Chowdhury · 1 shared paper, 2026 · strength 0.27
  6. Jason Roszik · 1 shared paper, 2026 · strength 0.27
  7. Scott Kopetz · 1 shared paper, 2026 · strength 0.27
  8. Arthur J. Liu · 1 shared paper, 2024 · strength 0.23
  9. David S. Hong · 1 shared paper, 2024 · strength 0.23
  10. Paul J. Chiao · 2 shared papers, 2018–2023 · strength 0.19
  11. Mien‐Chie Hung · 2 shared papers, 2018–2023 · strength 0.19
  12. Jianjun Gao · 1 shared paper, 2023 · strength 0.12
  13. Wei Hu · 1 shared paper, 2023 · strength 0.12
  14. Youqiong Ye · 1 shared paper, 2023 · strength 0.12
  15. Cheng‐Cao Sun · 1 shared paper, 2023 · strength 0.12
  16. Liuqing Yang · 1 shared paper, 2023 · strength 0.12
  17. Jun Yao · 1 shared paper, 2023 · strength 0.12
  18. Haoqiang Ying · 1 shared paper, 2023 · strength 0.12
  19. Dihua Yu · 1 shared paper, 2023 · strength 0.12
  20. George A. Călin · 1 shared paper, 2023 · strength 0.12
  21. Rishika Prasad · 1 shared paper, 2021 · strength 0.11
  22. Rosa F. Hwang · 1 shared paper, 2018 · strength 0.06
  23. Thiruvengadam Arumugam · 1 shared paper, 2018 · strength 0.06
  24. Liran Zhou · 1 shared paper, 2018 · strength 0.06
  25. Jianhua Ling · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.